PTC Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. PTC Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34% to $937,822,000. Profit margin reached -67%. Total operating expenses were $1,311,838,000.
Profit Margin
| 2014 | 22.96M | -93.75M | -408.28% |
|---|---|---|---|
| 2015 | 36.76M | -170.44M | -463.6% |
| 2016 | 82.70M | -142.11M | -171.83% |
| 2017 | 194.39M | -79M | -40.64% |
| 2018 | 264.73M | -128.08M | -48.38% |
| 2019 | 306.98M | -251.57M | -81.95% |
| 2020 | 380.76M | -438.16M | -115.07% |
| 2021 | 538.59M | -523.90M | -97.27% |
| 2022 | 698.80M | -559.01M | -80% |
| 2023 | 937.82M | -626.60M | -66.81% |
PTCT Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 937.82M | 698.80M | 538.59M | 380.76M | 306.98M | 264.73M | 194.39M | 82.70M | 36.76M | 22.96M |
Cost of revenue | 65.48M | 44.67M | 32.32M | 18.94M | 12.13M | 12.67M | 4.57M | 0 | 121.81M | 79.83M |
Gross profit | 872.33M | 654.12M | 506.26M | 361.82M | 294.84M | 252.06M | 189.81M | 82.70M | -85.05M | -56.87M |
Operating exp. | ||||||||||
Research and development | 666.56M | 651.49M | 540.68M | 477.64M | 257.45M | 171.98M | 117.45M | 117.63M | 121.81M | 79.83M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.31B | 1.09B | 881.20M | 759.69M | 487.64M | 348.40M | 254.10M | 214.76M | 203.89M | 122.37M |
Operating income | -349.40M | -439.92M | -374.94M | -397.87M | -192.79M | -115.68M | -64.29M | -132.05M | -167.13M | -99.41M |
Other income (expenses), net | -346.70M | -147.56M | -143.39M | -59.35M | -47.12M | -19.21M | -13.37M | -1.20M | -2.83M | 967K |
Income before tax | -696.11M | -587.48M | -518.34M | -402.93M | -239.92M | -128.11M | -77.66M | -141.54M | -169.96M | -98.44M |
Income tax expense | -69.50M | -28.47M | 5.56M | 35.22M | 11.65M | -29K | 1.33M | 569K | 485K | -4.69M |
Net income | -626.60M | -559.01M | -523.90M | -438.16M | -251.57M | -128.08M | -79M | -142.11M | -170.44M | -93.75M |
Earnings per share | ||||||||||
Basic EPS | -8.37 | -7.79 | -7.43 | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 | -5.07 | -2.97 |
Diluted EPS | -8.37 | -7.79 | -7.43 | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 | -5.07 | -2.97 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |